At a glance
ClinicalIndex Comparison Record- ✓Age ≥55 years
- ✓Prior cataract surgery with Alcon SN60WF or SA60AT monofocal IOL (17.0–24.0 D) with documented proof
- ✓Cataract surgery performed ≥6 months before planned IOPCL surgery
- ✓Prior Nd:YAG capsulotomy ≥1 month before planned IOPCL surgery
- ✕Prior cataract surgery with toric, multifocal, or accommodating IOL
- ✕Prior cataract surgery with Alcon SN60WF or SA60AT IOL power <17.0 D or >24.0 D
- ✕Neovascular (wet) AMD
- ✕No prior Nd:YAG capsulotomy
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Early Feasibility Study to Evaluate the Safety and Effectiveness of the Intraoperative Pseudophakic Capsular Lens Magnifier for Age-Related Macular Degeneration (IOPCL AMD-MAG) for Secondary Implantation in the Capsular Bag to Improve Near Vision in Subjects With Age-Related Macular Degeneration After Cataract Surgery
In Brief
A clinical study evaluating IOPCL AMD MAG for Low Vision and Age Related Macular Degeneration. Completed, enrolled 9 participants across 1 site.
Detailed Summary
This early feasibility study aims to improve near vision in subjects 55 years or older who have a clinical diagnosis of Age-Related Macular Degeneration. Subjects must have previously been implanted with either the Alcon Model SN60WF or Model SA60AT intraocular lens at least 6-months prior to receiving the IOPCL (intraocular pseudophakic capsular lens). Subject will be followed for a period of 12-months.
Study Details
Timeline
Interventions
The IOPCL MAG (intraocular pseudophakic capsular lens magnifier) consists of a 4.5 mm diameter optic. The central 1.8mm of the anterior surface has a power of 10.0 diopters. This IOPCL MAG will be implanted over an Alcon Model SN60WF or SA60AT intraocular lens to improve near vision.